SHMT2 and non-small cell lung carcinoma: Our multi-omics analysis of aggressive, early-stage non-small cell lung cancer (NSCLC) revealed PHGDH, PSAT1 and especially SHMT2 as highly up-regulated compared to normal lung as a consequence of proteome remodelling, and showed PSPH gene amplification linked with EGFR [9].